ATE326265T1 - Zusammensetzung aus dhea und calcitonin zur behandlung von subnormaler knochen-mineraldichte - Google Patents

Zusammensetzung aus dhea und calcitonin zur behandlung von subnormaler knochen-mineraldichte

Info

Publication number: ATE326265T1
Authority: AT; Austria
Prior art keywords: dhea; calcitonin; treatment; bone mineral; mineral density
Prior art date: 1999-11-12

Application number

AT00978330T

Other languages

English (en)

Inventor

Kenneth E Schwartz

Original Assignee

Genelabs Tech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-12

Filing date

2000-11-13

Publication date

2006-06-15

2000-11-13 Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE326265T1 publication Critical patent/ATE326265T1/de

Links

210000000988 bone and bone Anatomy 0.000 title abstract 2
FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical group C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 title abstract 2
229910052500 inorganic mineral Inorganic materials 0.000 title abstract 2
239000011707 mineral Substances 0.000 title abstract 2
102000055006 Calcitonin Human genes 0.000 title 1
108060001064 Calcitonin Proteins 0.000 title 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
229960004015 calcitonin Drugs 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 3
238000000034 method Methods 0.000 abstract 3
102000017631 Calcitonin-like Human genes 0.000 abstract 2
108050005865 Calcitonin-like Proteins 0.000 abstract 2
201000000596 systemic lupus erythematosus Diseases 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT00978330T 1999-11-12 2000-11-13 Zusammensetzung aus dhea und calcitonin zur behandlung von subnormaler knochen-mineraldichte ATE326265T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16508999P	1999-11-12	1999-11-12
US09/710,729 US6605591B1 (en)	1999-11-12	2000-11-10	Treatment of subnormal bone mineral density

Publications (1)

Publication Number	Publication Date
ATE326265T1 true ATE326265T1 (de)	2006-06-15

Family

ID=26861107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00978330T ATE326265T1 (de)	1999-11-12	2000-11-13	Zusammensetzung aus dhea und calcitonin zur behandlung von subnormaler knochen-mineraldichte

Country Status (16)

Country	Link
US (3)	US6605591B1 (de)
EP (1)	EP1231983B1 (de)
JP (1)	JP2003514026A (de)
KR (1)	KR20020063183A (de)
CN (1)	CN1411386A (de)
AT (1)	ATE326265T1 (de)
AU (1)	AU784160B2 (de)
BR (1)	BR0015534A (de)
CA (1)	CA2390431A1 (de)
DE (1)	DE60028074D1 (de)
IL (1)	IL149532A0 (de)
MX (1)	MXPA02004776A (de)
NO (1)	NO20022246L (de)
NZ (1)	NZ518791A (de)
RU (1)	RU2002115815A (de)
WO (1)	WO2001035975A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6605591B1 (en) *	1999-11-12	2003-08-12	Genelabs Technologies, Inc.	Treatment of subnormal bone mineral density
US7660453B2 (en)	2000-10-11	2010-02-09	Imaging Therapeutics, Inc.	Methods and devices for analysis of x-ray images
US8639009B2 (en) *	2000-10-11	2014-01-28	Imatx, Inc.	Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
EP1389947B1 (de)	2001-05-25	2009-08-26	Imaging Therapeutics, Inc.	Verfahren zur diagnose, behandlung und prävention von knochenverlust
US7840247B2 (en) *	2002-09-16	2010-11-23	Imatx, Inc.	Methods of predicting musculoskeletal disease
US8965075B2 (en) *	2002-09-16	2015-02-24	Imatx, Inc.	System and method for predicting future fractures
EP1605824A2 (de)	2003-03-25	2005-12-21	Imaging Therapeutics, Inc.	Verfahren zur kompensation der bildgebenden technik bei der bearbeitung von röntgenaufnahmen
US20050014734A1 (en) *	2003-07-18	2005-01-20	Genovate Biotechnology Co., Ltd.	Modulation of interleukin-10 by DHEA
CA2580726A1 (en)	2004-09-16	2006-03-30	Imaging Therapeutics, Inc.	System and method of predicting future fractures
WO2008034101A2 (en) *	2006-09-15	2008-03-20	Imaging Therapeutics, Inc.	Method and system for providing fracture/no fracture classification
EP2460515B1 (de) *	2007-08-09	2017-03-08	Novartis AG	Orale Calcitonin-Zusammensetzungen und ihre Anwendungen
MY149641A (en) *	2008-06-03	2013-09-13	Biffin John Ray	A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
US8939917B2 (en)	2009-02-13	2015-01-27	Imatx, Inc.	Methods and devices for quantitative analysis of bone and cartilage

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5175146A (en)	1989-12-05	1992-12-29	Vical, Inc.	Synthetic calcitonin peptides
WO1994008589A1 (en)	1992-10-09	1994-04-28	The Board Of Trustees Of The Leland Stanford Junior University	Treatment of systemic lupus erythematosus with dehydroepiandrosterone
US5776923A (en)	1993-01-19	1998-07-07	Endorecherche, Inc.	Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5912014A (en)	1996-03-15	1999-06-15	Unigene Laboratories, Inc.	Oral salmon calcitonin pharmaceutical products
EP0949928A4 (de)	1996-11-25	2000-09-13	Merck & Co Inc	Zusammen verabreichte androgene und diphosphonverbindungen zur behandlung von krankheiten
JP2001511811A (ja) *	1997-02-13	2001-08-14	ボーンケアインターナショナルインコーポレイテッド	ビタミンｄ化合物の標的治療放出
JP2002539158A (ja)	1999-03-18	2002-11-19	ジェネラブステクノロジーズ，インコーポレイテッド	Ｄｈｅａ組成物および方法
US7045513B1 (en)	1999-03-18	2006-05-16	Genelabs Technologies, Inc.	DHEA composition and method
US6605591B1 (en) *	1999-11-12	2003-08-12	Genelabs Technologies, Inc.	Treatment of subnormal bone mineral density

2000
- 2000-11-10 US US09/710,729 patent/US6605591B1/en not_active Expired - Fee Related
- 2000-11-13 CA CA002390431A patent/CA2390431A1/en not_active Abandoned
- 2000-11-13 CN CN00817384A patent/CN1411386A/zh active Pending
- 2000-11-13 MX MXPA02004776A patent/MXPA02004776A/es active IP Right Grant
- 2000-11-13 JP JP2001537966A patent/JP2003514026A/ja not_active Withdrawn
- 2000-11-13 IL IL14953200A patent/IL149532A0/xx unknown
- 2000-11-13 KR KR1020027006101A patent/KR20020063183A/ko not_active Ceased
- 2000-11-13 EP EP00978330A patent/EP1231983B1/de not_active Expired - Lifetime
- 2000-11-13 AU AU15802/01A patent/AU784160B2/en not_active Ceased
- 2000-11-13 AT AT00978330T patent/ATE326265T1/de not_active IP Right Cessation
- 2000-11-13 DE DE60028074T patent/DE60028074D1/de not_active Expired - Lifetime
- 2000-11-13 NZ NZ518791A patent/NZ518791A/en unknown
- 2000-11-13 BR BR0015534-9A patent/BR0015534A/pt not_active IP Right Cessation
- 2000-11-13 RU RU2002115815/14A patent/RU2002115815A/ru not_active Application Discontinuation
- 2000-11-13 WO PCT/US2000/030131 patent/WO2001035975A2/en not_active Ceased
2002
- 2002-05-10 NO NO20022246A patent/NO20022246L/no not_active Application Discontinuation
2003
- 2003-02-13 US US10/367,218 patent/US6854468B2/en not_active Expired - Fee Related
2004
- 2004-12-28 US US11/024,557 patent/US7612034B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6605591B1 (en)	2003-08-12
JP2003514026A (ja)	2003-04-15
WO2001035975A3 (en)	2001-12-27
AU1580201A (en)	2001-05-30
WO2001035975A2 (en)	2001-05-25
EP1231983B1 (de)	2006-05-17
MXPA02004776A (es)	2003-01-28
EP1231983A2 (de)	2002-08-21
RU2002115815A (ru)	2004-02-27
US20030158159A1 (en)	2003-08-21
IL149532A0 (en)	2002-11-10
NO20022246L (no)	2002-07-03
NZ518791A (en)	2004-03-26
NO20022246D0 (no)	2002-05-10
BR0015534A (pt)	2002-07-02
CN1411386A (zh)	2003-04-16
DE60028074D1 (de)	2006-06-22
US20050113301A1 (en)	2005-05-26
US6854468B2 (en)	2005-02-15
CA2390431A1 (en)	2001-05-25
AU784160B2 (en)	2006-02-16
US7612034B2 (en)	2009-11-03
KR20020063183A (ko)	2002-08-01

Legal Events

Date	Code	Title	Description
2006-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60028074D1 (de)	2006-06-22	Zusammensetzung aus dhea und calcitonin zur behandlung von subnormaler knochen-mineraldichte
ATE293883T1 (de)	2005-05-15	Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE320803T1 (de)	2006-04-15	Verfahren zur behandlung von alzheimerschen krankheit
DE69733611D1 (de)	2005-07-28	Verfahren und potenzierte zusammensetzung zur behandlung von migräne
ATE265213T1 (de)	2004-05-15	Noribogain zur behandlung von schmerzen und drogenabhängigkeit
ATE247950T1 (de)	2003-09-15	Fentanylzusammensetzung zur behandlung von akutem schmerz
TW200509956A (en)	2005-03-16	Compositions and methods for treatment of rosacea
BR9911748A (pt)	2001-04-03	Artigo absorvente, inserto para ser colocado em uma peça de vestuário do usuário, artigo descartável e processo para aumentar a capacidade de remoção de excreções corpóreas da pele de um usuário
DK0880350T3 (da)	2002-03-25	Behandling af dissemineret sklerose
BR9811780A (pt)	2000-09-12	Método de aumento de volume ósseo usando agonistas seletivos fp não ocorrendo naturalmente
WO2001001972A3 (en)	2001-12-06	SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
TW200505473A (en)	2005-02-16	Compositions and methods for treatment of psoriasis
DE69008258D1 (de)	1994-05-26	S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
ATE526980T1 (de)	2011-10-15	Zusammensetzungen und verfahren zur heilung von nervengeweben
AU6083301A (en)	2001-11-20	Treating eczema and/or psoriasis
ATE226058T1 (de)	2002-11-15	Verwendung von lysin zur behandlung des haarausfalls
GB2331301C (en)	2005-05-22	Galanin
AU2003248816A8 (en)	2004-01-23	Composition for lessening malodors during hair treatment and hair removal and method of use
ATE236169T1 (de)	2003-04-15	Heterocyclisch kondensierte morphinoid-derivate
ATE281841T1 (de)	2004-11-15	Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE282398T1 (de)	2004-12-15	Verfahren zum dauerwellen von menschlichen haaren
DE60129725D1 (de)	2007-09-13	Schwefel analoge von 21-hydroxy-6,19-oxidoprogesteronen (21oh-6op) zur behandlung von glucocorticoidüberschuss
ATE345138T1 (de)	2006-12-15	Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
ATE318612T1 (de)	2006-03-15	Methoden und zusammensetzungen zur behandlung der hyperlipidämie
ATA144696A (de)	1997-08-15	Vorrichtung zur behandlung von schenkenhalsfrakturen